Who
Paul A. Romness
President and CEO
Company insider
Files Form 4 as: President and CEO, OS Therapies.
In numbers
- Trades disclosed
- 8
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 5 Dec 2024
- Last trade
- 22 Jan 2026
- Last filed
- 15 May 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 Jan 2026filed 13 Feb 2026 | OSTX OS Therapiesoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,000,000 at $0.00 | filing |
| 22 Jan 2026filed 13 Feb 2026 | OSTX OS Therapiesoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,000,000 at $0.00 | filing |
| 21 Oct 2025filed 13 Feb 2026 | OSTX OS Therapiesoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,000,000 at $0.00 | filing |
| 21 Oct 2025filed 13 Feb 2026 | OSTX OS Therapiesoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,000,000 at $0.00 | filing |
| 21 Oct 2025filed 19 Dec 2025 | OSTX OS Therapiesoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,950,000 at $0.00 | filing |
| 28 Feb 2025filed 28 Feb 2025 | OSTX OS TherapiesBiotechnology | SEC FORM 4 Code J | —225,000 at $0.00 | filing |
| 5 Dec 2024filed 15 May 2026 | OSTX OS Therapiesoption or derivative · Biotechnology | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 5 Dec 2024filed 14 Feb 2025 | OSTX OS Therapiesoption or derivative · Biotechnology | SEC FORM 4 Code A | —800,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.